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Endovascular repair of ruptured abdominal aortic aneurysm in a Jehovah’s
Witness without blood transfusionSurgical repair of ruptured abdominal aortic aneurysm (AAA)
continues to carry a poor prognosis, with mortality rates of
45–50% and an overall mortality of 75–90%.1,2 The situation
becomes especially difﬁcult to salvage in patients who for religious
reasons refuse transfusion of all blood components. Since its advent
over a decade ago, endovascular aneurysm repair (EVAR) has
gained widespread acceptance in the elective setting, with
improved short-term survival ﬁgures compared to open repair.3
We have recent experience of a case of ruptured AAA in a Jehovah’s
Witness who refused allogeneic blood transfusion, in whom we
elected to undertake emergency endovascular repair.
The gentleman, a previously well 80-year-old, presented to
a neighbouring hospital with a sudden onset of severe right sided
back pain and a tense and tender abdomen. His initial haemoglobin
concentration was 12 g/dl. A computed tomography (CT) scan
demonstrated an 8 cm diameter infrarenal AAA with a large
right-sided retroperitoneal haematoma (Fig. 1). The infrarenal
aortic neck was angulated, but approximately 2 cm in length.
The patient was immediately transferred to the regional tertiary
referral centre for vascular surgery at Charing Cross Hospital and
taken directly to the operating theatre, by which time his systolic
blood pressure was ﬂuctuating between 60 and 80 mmHg. HisFig. 1. Pre-operative computed tomography. (A) Axial image showing the abdominal aortic
struction image showing the angulated neck of the aneurysm.
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directive from the patient, no blood components were transfused
during resuscitation, however, the patient agreed to the use of
the cell-saver.
Under local anaesthetic inﬁltration at both groins, a Talent
aorto-uniiliac modular stent-graft (Medtronic, Santa Rosa, Califor-
nia, USA) was deployed via the left common femoral artery. The
right common iliac artery, which was also aneurysmal, was
occluded using a 16 mm occluder graft deployed via the right
common femoral artery. The operation was completed with
a left-to-right femoro–femoral crossover bypass using a 10 mm
externally-reinforced polytetraﬂuoroethylene graft. Completion
angiography conﬁrmed patency of both renal and internal iliac
arteries. No endoleaks were detected. The operative time was 2 h
and 20 min. The total blood loss for the operation was 230 ml,
which was insufﬁcient to prime the cell-saver system and the blood
was therefore discarded. The post-operative haemoglobin concen-
tration was 7.8 g/dl.
The patient was alert and stable on the high dependency unit
24 h after the procedure. Follow-up imaging conﬁrmed satisfactory
graft position, exclusion of the aneurysm and the absence of
endoleak (Fig. 2).aneurysm and the right-sided retroperitoneal haematoma (arrow). (B) Sagittal recon-
d. All rights reserved.
Fig. 2. Three-dimensional reconstruction images of the post-operative computed
tomography angiogram. This shows the aorto-uniiliac stent graft, the right common
iliac artery excluder graft and the left-to-right femoro–femoral cross-over graft.
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48 h after the operation. Despite the absence of a general
anaesthetic there was a complicated post-operative course, with
the development of acute renal failure which responded well to
medical therapy. Hospital acquired pneumonia and bilateral pleural
effusions resulted in type II respiratory failure, and ventilatory
support via tracheostomy was required for four weeks. Erythropoi-
etin, vitamin B12, folic acid and iron supplementationwere admin-
istered, with blood sampling using paediatric bottles, and the
haemoglobin slowly recovered.
Eight weeks post operation he was making progress on the
rehabilitation ward. During his rehabilitation profuse sweating
became a prominent clinical feature, thought to be due to a combi-
nation of chest sepsis and an autonomic neuropathy attributed to
his prolonged intensive care unit stay. A further high dependency
unit admission for close monitoring of ﬂuid balance was followed
by a readmission to intensive care unit with sepsis and multi-organ
dysfunction, fromwhich the patient died 121 days after his original
presentation.
Endovascular repair, using an AneuRx (Medtronic, Santa Rosa,
California, USA) device, of a ruptured 9 cm abdominal aortic aneu-
rysm in a Jehovah’s Witness refusing blood transfusion has previ-
ously been described.4 This patient died on the second day afterrepair of anaemia resulting in myocardial infarction, shock and
multi-organ failure.
Wewould like to highlight some of EVAR’s advantages for use in
emergency aneurysm repair which are particularly pertinent to the
patient where ﬂuid resuscitation with blood components is not an
option. EVAR, as compared with open repair, has been shown to
signiﬁcantly reduce the need for transfusion of blood products in
the elective setting.5 The death of our patient at 121 days, however,
raises the issue that in the highest risk patients, the date of
expected death is not always altered by EVAR.6 The Immediate
Management of the Patient with aneurysm Rupture: Open Versus
Endovascular repair (IMPROVE) trial is due to commence recruit-
ment in September 2009 and will contribute to the evidence in
this area.7
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